Characterization of primary hepatic carcinosarcoma by contrast-enhanced ultrasonography: A case report

Abstract

Primary hepatic carcinosarcoma is a rare tumor and is comprised of a mixture of carcinomatous and sarcomatous elements. We present a case of primary carcinosarcoma of the liver in a 59-year-old woman, which was confirmed by pathology following surgical resection. Using contrast-enhanced ultrasonography, the tumor showed peripheral nodular hyperenhancement in the arterial phase with two feeding arterial vessels and a large internal non-enhancing portion in the center. The peripheral nodular portion of the tumor showed hypoenhancement in the later phase.

Core tip: Primary hepatic carcinosarcoma is a rare tumor and is comprised of a mixture of carcinomatous and sarcomatous elements, easily misdiagnosed as other types of tumor or an abscess. This is the first report on the contrast-enhanced ultrasonography characteristics of primary hepatic carcinosarcoma.

INTRODUCTION

Carcinosarcoma of the liver is defined as a tumor containing an intimate mixture of carcinomatous and sarcomatous elements[1]. Primary hepatic carcinosarcoma is rare with less than 30 adequately imaged documented cases reported[2-5]. We present a case of carcinosarcoma of the liver confirmed by pathology following surgical resection. To our knowledge there has been no report of CEUS of primary hepatic carcinosarcoma.

CASE REPORT

A 59-year-old woman was admitted to our hospital with a liver tumor. She had a high fever with cold symptoms for 1 mo before admission, and had been misdiagnosed with an abscess in a smaller hospital. The main biochemical indices of the liver were: serum alpha-fetoprotein (AFP) level of 221.7 μg/L, γ-glutamyl transpeptidase level of 67 U/L, serum total protein of 81.9 g/L, and total bile acid of 49 μmol/L. Serum markers for hepatitis B and C were negative. A history of hepatitis, tuberculosis, heart disease, hypertension or diabetes was denied.

Conventional ultrasonography (US) and contrast-enhanced ultrasonography (CEUS) were performed using a Technos MPS DU8 sonography system (Esaote Genova, Italy). CEUS software allows real-time imaging at a low mechanical index (MI). The contrast agent used in this study was SonoVue (Bracco, Milan, Italy). The patient gave her full informed consent for SonoVue injection, which was injected intravenously as a bolus of 2.4 mL through the antecubital vein followed by a 5-mL saline flush. The perfusion and enhancement of the lesion were continuously observed until sufficient dynamic information on the lesions was obtained, and the entire liver was then scanned. The MI value was 0.8 on CEUS.

Baseline sonogram of the liver showed both a coarse echo pattern and surface nodularity, which are sonographic signs of cirrhosis. At the same time, an ovoid heterogeneous echogenic mass within the right lobe of the liver was noted (Figure 1A). The tumor was 6.5 cm × 6.6 cm in size. Color Doppler imaging showed that the tumor had compressed the right hepatic vein (Figure 1B). CEUS displayed peripheral nodular enhancement of the tumor in the early arterial phase with two feeding arterial vessels and a large internal non-enhancing portion in the central area (Figure 2A). The peripheral nodular portion of the tumor was hyper-enhancing and iso-enhancing in the portal phase (Figure 2B) and hypo-enhancing in the later phase (Figure 3C). The large internal portion was non-enhancing in all three phases.

Figure 1.

Conventional ultrasonography of a primary hepatic carcinosarcoma. A: Gray-scale ultrasonography showed an ovoid heterogeneous echogenic mass in the right liver; B: Color doppler imaging showed the right hepatic vein compressed by the mass (arrow).

Figure 2.

Contrast-enhanced ultrasonography of a primary hepatic carcinosarcoma. A: Contrast-enhanced sonography showed early intense peripheral nodular enhancement in the arterial phase (21 s) with two feeding arteries (arrows); B: Peripheral nodular portion of the tumor was iso-enhancing compared to the surrounding liver in the portal phase (76 s); C: Peripheral nodular portion of the tumor was washed out and was hypo-enhanced compared to the liver in the later phase (191 s).

Figure 3.

Contrast-enhanced computed tomographic of a primary hepatic carcinosarcoma. A: Contrast-enhanced computed tomographic revealed peripheral nodular enhancement in the arterial phase with a large internal non-enhancing portion, which correlated with contrast-enhanced ultrasonography findings; B: Peripheral nodular portion of the tumor was isoenhanced in the portal phase.

Computed tomographic (CT) scan of the tumor revealed peripheral nodular enhancing portions in the arterial phase with large internal non-enhancing necrotic portions (Figure 3A). The peripheral nodular portion of the tumor was iso-enhancing in the portal phase (Figure 3B). Enhanced-CT imaging features were the same as contrast-enhanced sonography.

The patient underwent surgical resection. The liver was found to be cirrhotic with a nodular surface. It was a large mass without daughter nodules. However, the middle hepatic vein was impinged by a thrombus, which was resected with complete removal of the hepatic venous thrombus.

Macropathology of the tumor showed that it was grayish-white, grayish-red and soft, with hemorrhagic necrosis (Figure 4A). The surrounding organizational boundaries were unclear, with central gray, gelatinous tissue. The mass measured 8 cm × 7 cm × 6 cm with no capsule. The diagnosis was carcinosarcoma containing both hepatocellular and sarcomatous elements (Figure 4B-D). Furthermore, the thrombus in the middle hepatic vein was metastasis.

Figure 4.

Pathologic findings of the primary hepatic carcinosarcoma (hematoxylin and eosin, original magnification × 200). A: A section of the gross specimen showing a well-demarcated, peripheral nodular solid mass with a central area of necrosis and hemorrhage; B: Light microscopy showing moderate hepatocellular carcinoma; C: Stromal sarcoma components are comprised of spindle cells; D: Atypical spindle and epithelial cells are seen, which are consistent with hepatic carcinosarcoma.

The patient was discharged after 31 d of hospitalization. She then received chemotherapy. Seventeen days after discharge, she was re-admitted with hepatic decompensation due to hepatorenal syndrome, portal hypertension and ascites. Subsequently, peritoneal thickening and enlarged abdominal lymph nodes were found. She died of recurrence 50 d after surgery.

DISCUSSION

Carcinosarcoma is a miscellaneous tumor[1]. The World Health Organization (WHO) defined carcinosarcoma as a tumor containing both carcinomatous (either hepatocellular or cholangiocellular) and sarcomatous elements. It is a malignant mixed tumor. Including the present case, less than 30 cases of carcinosarcoma fulfilling the WHO criteria have been reported in PubMed. Hepatic carcinosarcoma generally has a highly aggressive and malignant biological course with rapid growth and local infiltration[6].

Kwon et al[7] reported a case of carcinosarcoma of the liver with cholangiocarcinomatous elements and osteosarcomatous and chondrosarcomatous elements. CT analysis of this tumor revealed peripheral enhancing viable portions, large internal non-enhancing necrotic portions, and a dense radiopaque lesion. On magnetic resonance imaging, this tumor was observed, on T2-weighted images, to have slightly hyperintense peripheral viable portions, moderately hyperintense internal necrotic portions, and very hyperintense small central cystic portions. In addition, calcification and ossification had low or dark signal intensity on T1- and T2-weighted images.

Sumiyoshi et al[6] observed one case of hepatic carcinosarcoma which was demonstrated to be embryonal sarcoma in cholangiocarcinoma. This carcinosarcoma on magnetic resonance imaging revealed hypointensity on T1-weighted images and heterogeneous hyperintensity on T2-weighted images. Shu et al[5] reported one case of liver carcinosarcoma, and triple-phase contrast CT revealed a mixed density mass with inhomogeneous enhancement, multiple cystic nodules and irregular rim enhancement. They demonstrated that the hepatic carcinosarcoma CT presentation was unspecific and the pre-operative diagnosis was difficult.

Deng et al[8] described one case that was misdiagnosed as liver abscess by baseline sonography. Contrast-enhanced CT revealed a hepatic malignant tumor (AFP, 202 μg/L). After surgery, the tumor was diagnosed as primary hepatic carcinosarcoma with necrotic and cystic elements based on pathology.

Low mechanical index real-time CEUS is a new US technique which improves the differential diagnosis of focal liver lesions. Hepatic focal nodular hyperplasia (FNH) appears spoke wheel-shaped with a centrifugal filling contrast enhancement pattern in the early artery phase on CEUS[9]. In the portal or later phase, some FNHs may show central scars[10]. Hemangiomas show peripheral enhancement that gradually fills in the arterial phase[11]. However, the present case demonstrated peripheral nodular enhancement with two feeding artery vessels in the arterial phase without gradual fill-in. Furthermore, there was slight hypoenhancement of the peripheral nodular area in the later phase with a large non-enhanced center in the three phases, which is different from typical hepatocellular carcinoma (HCC) and liver metastatic tumors. Typically, HCC appears with homogeneous hyperenhancement during the arterial phase and hypoenhancement during the portal or/and late phases[12]. Typically, hepatic metastasis shows peripheral rim-like or variable intralesional enhancement during the arterial phase, and often marks hypoenhancement during the portal and late phases[13]. The CEUS enhancement patterns of different hepatic tumors are summarized in Table 1.

Table 1.

Typical contrast-enhanced ultrasonography characteristics of various liver tumors

Tumor	In the artery phase	In the portal phase	In the late phase
FNH	Spoked-wheel enhancement	Hyperenhancing/or with scar	Iso/hyperenhancing/or with scar
Hemangiomas	Peripheral nodular enhancement and centripetal fill-in	Partial/complete centripetal fill-in	Partial/complete centripetal fill-in
HCC	Hyperenhancing	Iso/hypoenhancement	Hypoenhancing
Metastatic tumor	Rim-like or variable intralesional enhancement	Homogeneous or heterogeneous hypoenhancement	Hypoenhancement (often marked hypoenhancement)
Hepatic carcinosarcoma	Peripheral nodular or irregular rim enhancement with large internal non-enhancing area	Peripheral isoenhancing with large internal non-enhancement area	Peripheral hypoenhancing with large internal non-enhancement area

FNH: Focal nodular hyperplasia; HCC: Hepatocellular carcinoma.

The imaging findings of hepatic carcinosarcoma presented in our case showed a large mass with a large necrotic portion. It is difficult to establish an accurate preoperative diagnosis. However, if a primary hepatic tumor exhibits a large necrotic mass, carcinosarcoma should be considered. Conventional sonography is usually the first imaging technique used in patients with carcinosarcoma, and CEUS plays an important role in demonstrating primary liver carcinosarcoma enhancement patterns.

COMMENTS

Case characteristics

The patient had high fever with cold symptoms for 1 mo.

Clinical diagnosis

The patient had primary hepatic tumor with cirrhosis and an alpha-fetoprotein (AFP) level of 221.7 μg/L.

Differential diagnosis

Contrast-enhanced ultrasonography, computed tomographic scan and serum AFP determination helped in the differential diagnosis.

Laboratory diagnosis

Serum markers for hepatitis B and C were negative, but serum AFP level was 221.7 μg/L.

Imaging diagnosis

On contrast-enhanced ultrasonography (CEUS), the tumor showed peripheral nodular hyperenhancement in the arterial phase with two feeding arterial vessels and a large internal non-enhancing portion in the center.

Treatment

The patient underwent surgical resection of the tumor and received chemotherapy.

Related reports

The tumor revealed a large internal non-enhancing portion in the center, easily misdiagnosed as a liver abscess, however, peripheral nodular hyperenhancement in the arterial phase and AFP level helped in the diagnosis of malignancy.

Experiences and lessons

The tumor showed a large internal non-enhancing portion in the center, easily misdiagnosed as a liver abscess in patients with high fever. Furthermore, peripheral nodular hyperenhancement in the arterial phase may easily be misdiagnosed as a hemangioma, but without gradual fill-in and the presence of cirrhosis, and elevated AFP level helped in the diagnosis of malignancy.

Peer review

The authors reported on the rare CEUS characteristics of a primary hepatic carcinosarcoma, and the contrast enhanced-computed tomographic imaging, pathologic and surgical specimen findings. The paper has interesting information about a rare disease with new technology for the diagnosis.